- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
Source: The post is based on the article “Union Minister launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine” published in PIB on 23rd June 2023
What is the News?
The Union Minister of Science and Technology has launched GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine.
What is GEMCOVAC-OM?
GEMCOVAC-OM is an indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus.
It is India’s first mRNA vaccine.
Developed by: Pune based Gennova Biopharmaceuticals with funding support from the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC).
Features: It is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines.
– It is delivered intra-dermally using a needle-free injection device system.
– It will for now only be available as a booster or “precaution dose”.
